Zeria Pharmaceutical Co Ltd (4559) – aksjekurser og nyheter

Symboler Symboler	Pris	Endring	Endring (%)	Trend	Forrige pris ved stengetid	Åpne	Høy	Lav	Volum	Markedsverdi
SIXB Materials SIXB Materials	SIXB +0,25%	1 104,10	+2,73	+0,25%	—	1 101,37	1 103,63	1 105,31	1 091,41	—	—
SIXC Communications SIXC Communications	SIXC −1,50%	604,16	−9,19	−1,50%	—	613,35	613,35	613,35	601,49	—	—
SIXE Energy SIXE Energy	SIXE −0,09%	1 197,81	−1,02	−0,09%	—	1 198,83	1 199,68	1 199,75	1 182,41	—	—
SIXI Industrials SIXI Industrials	SIXI −0,88%	1 740,41	−15,54	−0,88%	—	1 755,95	1 754,06	1 756,03	1 734,69	—	—
SIXM Financials SIXM Financials	SIXM −0,64%	634,44	−4,07	−0,64%	—	638,51	637,41	637,41	633,05	—	—
SIXR Staples SIXR Staples	SIXR −0,31%	840,90	−2,62	−0,31%	—	843,52	843,35	846,40	837,93	—	—
SIXRE Real estate SIXRE Real estate	SIXRE −0,38%	215,13	−0,82	−0,38%	—	215,95	215,95	216,84	215,06	—	—
SIXT Technology SIXT Technology	SIXT +2,86%	3 228,71	+89,80	+2,86%	—	3 138,91	3 189,30	3 230,85	3 174,76	—	—
SIXU Utilities SIXU Utilities	SIXU +0,16%	935,87	+1,50	+0,16%	—	934,37	934,72	938,26	927,50	—	—
SIXV Health care SIXV Health care	SIXV −1,37%	1 457,12	−20,31	−1,37%	—	1 477,43	1 474,12	1 474,12	1 451,80	—	—
SIXY Discretionary SIXY Discretionary	SIXY +0,83%	2 399,84	+19,65	+0,83%	—	2 380,19	2 389,34	2 403,04	2 380,47	—	—

4559:TYO

Zeria Pharmaceutical Co Ltd

2 196,00 JPY

+0,41%

(+9,00) 1 D

27. apr., 09:09:02 GMT+9 · JPY

Alle symboler

1 D

5 D

1 M

6 M

I år

1 Å

5 Å

MAKS

	Symbol	Pris	Endring	Endring (%)

Genererer viktig statistikk for 4559 …

Åpne

2 191 JPY

Høy

2 208 JPY

Lav

2 187 JPY

Markedsverdi

110,51 mrd.

Snittvolum

92,05k

Volum

5,80k

Utbytte

2,19 %

Kvartalsvis utbytte

12 JPY

Første dato etter utbytte

29. sep. 2025

P/E-forhold

13,33

52 u høy

2 378 JPY

52 u lav

1 878 JPY

EPS

165 JPY

Utestående aksjer

50,11 mill.

Antall ansatte

Relaterte aksjer

Rohto Pharmaceutical Co Ltd

2 378,00 JPY

−0,15%

4568

Daiichi Sankyo Co Ltd

Nyhetssaker

Fra kilder på nettet

조선일보

for 33 minutter siden

Active ETFs Outperform Nasdaq via AI Infrastructure Shift

MSN

for 53 minutter siden

The stock market recently did something witnessed only once before in 154 years -- and history is very clear about what happens next

Yahoo Finance

for 56 minutter siden

Stock market today: S&P 500, Nasdaq, Dow futures slide with Hormuz closure, Mag 7 earnings in focus

Simply Wall Street

for 1 time siden

Assessing Amazon.com (NasdaqGS:AMZN) Valuation After Major AI Chip And Cloud Deals With Meta And Anthropic

Profil

Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG. In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK. In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988. In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries, It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma. The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries. The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia

Om Zeria Pharmaceutical Co Ltd

Administrerende direktørSachiaki Ibe

Ansatte1,75k

Grunnlagt22. des. 1955

Hovedkontor-

Sektor-

Nettstedzeria.co.jp

Alle verdier i JPY	mars 2025	juni 2025	sep. 2025	des. 2025
Inntekt	22,54 mrd.	19,49 mrd.	20,47 mrd.	24,12 mrd.
Varekostnad	6,05 mrd.	5,58 mrd.	5,59 mrd.	6,38 mrd.
Direkte driftskostnader	6,05 mrd.	5,58 mrd.	5,59 mrd.	6,38 mrd.
Utgifter til forskning og utvikling	4,11 mrd.	-	-	-
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	4,58 mrd.	12,39 mrd.	12,76 mrd.	12,82 mrd.
Driftskostnader	14,54 mrd.	12,39 mrd.	12,76 mrd.	12,82 mrd.
Totale driftskostnader	20,59 mrd.	17,97 mrd.	18,35 mrd.	19,19 mrd.
Driftsinntekter	1,95 mrd.	1,52 mrd.	2,12 mrd.	4,93 mrd.
Andre ikke-operasjonelle inntekter	−51,00 mill.	25,00 mill.	−23,00 mill.	−81,04 mill.
EBT inkludert uvanlige elementer	2,16 mrd.	1,66 mrd.	994,00 mill.	4,63 mrd.
EBT uten uvanlige elementer	2,18 mrd.	1,66 mrd.	994,00 mill.	4,63 mrd.
Kostnad for inntektsskatt	397,00 mill.	624,00 mill.	383,00 mill.	795,44 mill.
Faktisk avgiftssats	18,34 %	37,61 %	38,53 %	-
Andre driftskostnader	-	-	-	-
Nettoinntekt	1,71 mrd.	1,09 mrd.	647,00 mill.	3,82 mrd.
Netto fortjenestemargin	7,59 %	5,59 %	3,16 %	-
Resultat per aksje	-	-	-	-
Rente- og investeringsinntekter	95,00 mill.	279,00 mill.	30,00 mill.	136,71 mill.
Rentekostnader	−114,00 mill.	−121,00 mill.	−119,00 mill.	−123,00 mill.
Netto rentekostnader	−19,00 mill.	158,00 mill.	−89,00 mill.	13,71 mill.
Avskrivnings- og amortiseringskostnader	5,85 mrd.	-	-	-
EBITDA	3,84 mrd.	3,41 mrd.	3,88 mrd.	6,81 mrd.
Gevinst eller tap ved salg av eiendeler	-	-	-	-

AI-innhold kan inneholde feil. Finn ut mer

HjelpSend tilbakemeldingPersonvern Vilkår Ansvarsfraskrivelse

Finance

Utforskning